FLUENT Corp. (CSE: FNT.U; OTCQB: CNTMF) on Friday said it has entered into a definitive agreement to sell its Texas business, including cultivation, manufacturing, delivery and retail operations, to Legacy Therapeutics for $30 million. Under the deal, $25 million will be paid at closing, with two additional $2.5 million payments due on the first and […]